2nd ESNI Course | 27 – 30 June 2001
DAY ONE
Chairs: R. Liblau and C. Linington
PROTECTIVE VS DETRIMENTAL AUTOIMMUNITY
08.45-09.00
Introductory remarks
09.00-09.40
Natural autoimmunity (M. Kazatchkine)
09.50-10.30
Autoimmunity and its regulation (J-F Bach)
10.40-11.00
Coffee Break
11.00-11.40
Protective autoimmunity (M. Schwartz)
11.50-12.30
CNS autoimmunity and thymic expression of self-antigens (V. Kuchroo)
12.40-15.00
Lunch
15.00-15.40
Oligodendrocyte directed autoimmunity (C. Linington)
15.50-16.30
Autoimmunity against astrocytes (R. Liblau)
16.30-17.00
Coffee Break
17.00-17.40
Autoimmunity against neurons in the context of paraneoplastic neurological syndromes (R. Darnell)
17.50-18.30
Autoimmunity in animal models of multiple sclerosis (H. Lassmann)
DAY TWO
Chairs: N. Baumann and N. J. Scolding
NEUROIMMUNE INTERPLAY
09.00-09.40
Interactions between T-cells and glia (F. Aloisi)
09.50-10.30
Cytokine control of neuron survival (H. Gascan)
10.40-11.00
Coffee Break
11.00-11.40
Inflammatory responses in the CNS (H. Perry)
11.50-12.30
Lymphocyte-endothelial cell dialogue (D. Male)
12.40-15.00
Lunch
15.00-15.40
Neuroimmune interplay in the thymus in myasthenia gravis (S. Berrih-Aknin)
15.50-16.30
Alzheimer’s disease and neuroinflammation (P. McGeer)
16.30-17.00
Coffee Break
17.00-17.40
The neuro-endocrine system and autoimmunity (S. Lightman)
17.50-18.30
Prion diseases and the immune system (A. Aguzzi)
DAY THREE
Chairs: R. Hohlfeld and H-P. Hartung
IMMUNOTHERAPY
09.00-09.40
Basis of immunotherapy of CNS diseases (L. Adorini)
09.50-10.30
Mechanisms of glatiramer acetate and interferon-beta: what can we learn for future therapies (R. Hohlfeld)
10.40-11.00
Coffee Break
11.00-11.40
Therapeutic use of immunoglobulin (R. Gold)
11.50.12.30
Cochrane systematic reviews of treatment for inflammatory neuropathy (R. Hughes)
12.40-15.00
Lunch
15.00-15.40
Autoimmunity at the neuromuscular junction (J. Newsom-Davis)
15.50-16.30
Immunotherapy of inflammatory myopathies (M. Dalakas)
16.30-17.00
Coffe Break
17.00-17.40
Current concepts of multiple sclerosis therapy (H-P. Hartung)
17.50-18.30
Immunotherapy for paraneoplastic neurological autoimmune diseases (R. Voltz)
DAY FOUR
Chairs: D. Karussis and G. Martino
STEM CELLS THERAPY
09.00-09.40
Neural stem cells: transdifferentiation (A. Vescovi)
09.50-10.30
Identification of neural stemm cells in the embryo and in the adult brain (C. Johansson)
10.40-11.00
Coffee Break
11.00-11.40
Neuronal stem cells and neuronal spheres (M. Dubois-Dalcq)
11.50-12.30
The concept of haemopoetic stem cells transplantation in autoimmunity (S. Slavin)
12.40-15.00
Lunch
15.00-15.40
Schwann cell transplantation and myelin repair in CNS and PNS (B. Van Evercoreen)
15.50-16.30
Experience with neuronal stem cells transplantation in models of neuroimmune diseases (T. Ben-Hur)
16.30-17.00
Coffee Break
17.00-17.40
Transplantation of embryonic stem cells-derived neural precursors (O. Brustle)
17.50-18.30
Embryonic neuronal cells transplantation in CNS degenerative diseases (M. Pechanski)
18.30-18.45
Concluding remarks
Organizing Committee
• Reinhard Hohlfeld (Germany)
• Dimitrios Karussis (Israel)
• Nils Erik Gilhus (Norway)
• Roland Liblau – Local Organizer (France)
• Gianvito Martino (Italy)
• Neil Scolding (UK)
